| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
Chain Gene as a Marker of Lineage and Clonality in T-Cell Lymphoproliferative Disorders1
First Department of Internal Medicine [N. K., T. A., T. K., S. H., M. O.] and The First Department of Pathology [T. Y., K. O., M. K.], Fukuoka University School of Medicine, 7-45-1 Nanakuma, Jonan-ku, Fukuoka 814-01, Japan; The Department of Biophysics, Ontario Cancer Institute, University of Toronto, Ontario, M4X 1K9, Canada; [Y. T.] and the Department of Hematology, National Kyushu Cancer Center Hospital, 3-1-1 Notame, Fukuoka 815, Japan [M. K.]
We analyzed the rearrangement of T-cell receptor (TcR)
chain gene in 88 cases of lymphoproliferative disorders; 31 acute lymphoblastic leukemias/lymphoblastic lymphomas (ALL/LBL); 27 adult T-cell leukemias/lymphomas, 9 angioimmunoblastic lymphoadenopathies (AILD); 10 T-cell lymphomas (non-Hodgkin's lymphoma); and 11 Hodgkin's disease. All of 9 T-ALL/LBL cases, of which 4 cases have neither ß nor
gene rearrangement, had a new rearranged band of TcR
locus. Ten of 16 B-lineage ALL/LBL had rearranged band(s) or deletion of TcR
locus. The rearranged bands were recognized in 2 cases of AILD and 1 case of T-cell lymphoma. All cases of adult T-cell leukemias/lymphomas, 4 of AILD, 4 of T-cell lymphoma, and 8 of Hodgkin's disease had deleted TcR
locus. Heterogeneous findings of TcR
locus analysis were observed in AILD, T-cell lymphoma, and Hodgkin's disease. In 16 cases with TcR
rearrangement, the J
1 region was frequently used and the J
2 region was rearranged in one AILD. It is suspected that J
3 was used in one T-ALL/LBL. There was no correlation between the phenotypic pattern of CD3, CD4, CD8 in T-cell disorders and the rearrangement of the TcR
gene. These findings suggest that the newly identified TcR
chain gene rearranges at a very early stage of T-cell ontogeny; prior to the other TcR genes and perhaps at almost the same stage with CD7 expression. The TcR
gene is useful in assessing clonality for the most immature T-cell neoplasms not showing rearrangement of the other TcR genes. This gene is not lineage specific; however, when used in conjunction with immunoglobulin heavy chain gene, it may be a useful tool to distinguish lymphoid lineage of ALL/LBL.
1 This work was supported in part by Grant-in-Aid for Scientific Research 63570579 from the Ministry of Education, Science and Culture, Japan, and by Grant 1567 from the Naito Foundation and Grant 63235 from the Fukuoka Anti-Cancer Society.
2 To whom requests for reprints should be addressed, at The First Department of Internal Medicine, Fukuoka University School of Medicine, 7-45-1 Nanakuma, Jonan-ku, Fukuoka 814-01, Japan.
Received 2/14/89. Revised 5/ 8/89. Accepted 5/11/89.
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Cancer Research | Clinical Cancer Research |
| Cancer Epidemiology Biomarkers & Prevention | Molecular Cancer Therapeutics |
| Molecular Cancer Research | Cancer Prevention Research |
| Cancer Prevention Journals Portal | Cancer Reviews Online |
| Annual Meeting Education Book | Meeting Abstracts Online |